Envoy Medical COCH Cash Flow Statement (2021-2026)

NASDAQ COCH
$0.70 +0.01 (+1.56%)
As of: Sep 10, 2026 · 1:59 PM EDT
Reported Financials

Envoy Medical Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Envoy Medical reported cash from operations of -$5.46M and free cash flow of -$5.46M for the quarter ended Jun 2026, down 22.3% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
5.57M-4.72M12.46M3.09M5.69M-2.01M0.72M-1.14M-3.38M-6.72M-4.92M-4.98M-5.24M-4.93M-5.60M-5.69M-6.18M-6.38M-5.96M-5.57M
Share-based CompensationStock Comp.
0.26M1.97M2.00M2.05M2.07M-0.29M2.30M0.15M0.17M0.18M0.24M3.95M
Deferred Taxes
-0.46M-0.06M-0.02M-0.01M
Gains from Investment SecuritiesGains Investment
-8.55M4.00M-14.40M-3.47M-1.33M-20.02M0.27M-0.16M-1.05M0.26M-0.24M0.31M-0.74M-0.42M-0.04M-0.06M-0.01M0.01M-0.02M
Asset Writedowns and ImpairmentWritedown
-0.03M-0.01M-0.00M-0.10M0.02M0.09M0.17M-0.02M0.03M0.06M-0.03M0.01M0.01M
Cash from OperationsCash from Ops.
-0.70M-0.89M-0.77M-0.40M-5.25M-2.38M-3.01M-4.03M1.10M-11.14M-5.59M-4.65M-2.62M-5.09M-3.73M-4.46M-4.33M-5.68M-6.06M-5.46M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.26M0.38M0.49M0.62M0.47M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.06M-0.03M0.04M0.05M0.11M-0.14M0.25M0.02M-0.16M0.00M0.00M-0.01M-0.00M-0.00M0.02M
Change in InventoryChange Inventory
-0.03M0.11M-0.09M0.14M0.30M-0.20M0.14M-0.07M-0.04M0.11M-0.12M-0.04M0.10M
Change in Account PayablesChange Payables
0.75M-0.18M0.04M0.23M-0.51M0.58M1.02M0.34M2.64M-3.45M-0.64M0.68M0.17M-0.22M0.01M-0.04M1.01M0.41M-1.22M0.31M
Change in Accured ExpensesChange Accured Exp.
1.54M0.09M0.58M-0.47M-0.21M0.24M-0.18M0.32M0.56M-0.79M-0.36M-0.98M1.30M0.93M0.20M0.11M-0.10M-1.08M0.66M-0.91M
Change in TaxesChange Taxes
-0.26M0.24M-0.53M1.71M
Investing Activities
Capital ExpendituresCapex
0.04M0.06M0.01M0.06M0.02M0.11M0.43M0.97M-0.53M0.01M0.00M0.05M0.12M
Cash from Investing ActivitiesCash from Investing
-0.04M-0.06M-0.01M-0.06M-0.02M-0.11M-0.79M-0.61M0.53M-0.01M-0.00M-0.17M
Financing Activities
Other financing activitiesOther financing
18.60M0.26M0.26M0.43M1.11M0.23M0.24M0.16M4.00M0.21M0.21M
Cash from Financing ActivitiesCash from Financing
-0.01M0.00M0.75M0.75M4.59M2.00M4.00M3.00M15.74M-1.45M6.43M2.24M5.92M5.62M3.55M4.44M2.60M6.04M27.57M-0.11M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.09M0.03M0.29M0.09M0.35M
Net Equity Issued and RepurchasedNet Equity Issued
1.68M0.21M30.00M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.61M1.21M0.61M1.91M3.73M-3.63M
Additional items
Exchange Rate EffectFX Effect
-0.01M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.01M-0.00M-0.00M-0.00M-0.00M
Change in Cash
-0.71M-0.88M-0.02M0.35M-0.84M-0.43M0.93M-1.05M16.77M-12.62M0.73M-3.20M2.68M1.06M-0.17M-0.03M-1.73M0.18M21.51M-5.57M
Free Cash FlowFCF
-0.70M-0.89M-0.77M-0.40M-5.25M-2.42M-3.07M-4.04M1.04M-11.17M-5.70M-5.08M-3.60M-4.56M-3.73M-4.46M-4.38M-5.81M-6.06M-5.46M
Net Cash FlowNCF
-0.71M-0.88M-0.02M0.35M-0.66M-0.42M0.93M-1.04M16.77M-12.62M0.73M-3.20M2.68M1.06M-0.18M-0.02M-1.73M0.18M21.51M-5.57M